MESOTELIOMA

PROMISE-Meso
BEAT-Meso

PROMISE-Meso

Multicentre randomised phase III trial comparing pembrolizumab versus standard chemotherapy for advanced pre-treated malignant pleural mesothelioma.

Promotor: ETOP
Coordinador en España: Dr. Ernest Nadal

Centros participantes

Institut Català d’Oncologia-Hospitalet
Hospital Clínico Universitario de Valladolid
Hospital Teresa Herrera, A Coruña

BEAT-Meso

A multicentre randomised phase III trial comparing atezolizumab plus bevacizumab and standard chemotherapy versus bevacizumab and standard chemotherapy as first-line treatment in advanced malignant pleural mesothelioma

Promotor: ETOP
Coordinador en España: Dr. Enriqueta Felip and Dr. Sanjay Popat

Centros participantes

Hospital Parc Taulí Sabadell
Hospital Univ. Virgen del Rocio
Hospital Univ. General de Alicante
Complejo Hospitalario de Vigo
Hospital Univ. Puerta de Hierro
Hospital Univ. Vall d’Hebron
ICO Hospitalet